Isocitrate Dehydrogenase Mechanisms and Characterization

Isocitrate dehydrogenases (IDHs) are pivotal enzymes in the tricarboxylic acid cycle, catalysing the oxidative decarboxylation of isocitrate to α-ketoglutarate with concomitant reduction of nicotinamide cofactors. Eukaryotic forms typically assemble as heterotetramers or heterooctamers composed of distinct α, β and γ subunits, whereas prokaryotic enzymes display a diversity of oligomeric states and cofactor preferences. Structural studies have revealed conserved catalytic cores flanked by regulatory domains that mediate allosteric activation by metabolites such as citrate, ADP and ATP. Variations in coenzyme specificity (NAD+ versus NADP+), metal-ion coordination and subunit interactions underpin functional adaptability across phylogenetic lineages. Recent advances in high-resolution crystallography, mutagenesis and kinetic characterisation have deepened understanding of subunit roles, effector binding pathways and the evolutionary emergence of dual coenzyme specificity, with implications for metabolic regulation and disease-associated IDH variants.

Research from Nature Portfolio

Investigations into human NAD-dependent IDH have delineated distinct structural and functional roles for the β and γ subunits. Biochemical and mutational analyses demonstrate that the γ subunit imparts allosteric activation by citrate and ADP, while the β subunit primarily stabilises the heterotetrameric assembly to enable full catalytic efficiency. Separate structural elucidation of the αγ heterodimer bound to activators has mapped conformational changes at an allosteric site that propagate to the active centre, revealing a synergistic mechanism whereby citrate binding induces a reorganisation stabilising isocitrate and ADP further reinforces this effect via Mg2+-mediated coordination. Complementary work has uncovered the molecular basis of NADH inhibition, showing that NADH binds competitively at both the active and regulatory sites of the αγ dimer, thereby blocking cofactor and effector access and attenuating enzyme turnover. Together, these studies form a cohesive picture of subunit cooperation, allosteric signal transmission and feedback inhibition in mammalian IDH.

Isocitrate Dehydrogenase Mechanisms and Characterization publication trend

The graph below shows the total number of articles in isocitrate dehydrogenase mechanisms and characterization across all publications each year (not limited to Nature Index journals).

Technical terms

Isocitrate dehydrogenase (IDH): Enzyme catalysing oxidative decarboxylation of isocitrate to α-ketoglutarate in the citric acid cycle.
Allosteric regulation: Modulation of enzyme activity by effector molecules binding at sites distinct from the active site.
Coenzyme specificity: Preference of an enzyme for NAD+ or NADP+ as an electron carrier.
Heterotetramer/heterooctamer: Multimeric enzyme assemblies composed of different subunit types.
α-Ketoglutarate: Product of the IDH reaction and a key metabolic intermediate.
Catalytic efficiency: Ratio of turnover number (kcat) to Michaelis constant (Km), indicating enzyme proficiency.

References

1. The β and γ subunits play distinct functional roles in the α2βγ heterotetramer of human NAD-dependent isocitrate dehydrogenase. Scientific Reports (2017).
2. Molecular mechanism of the allosteric regulation of the αγ heterodimer of human NAD-dependent isocitrate dehydrogenase. Scientific Reports (2017).
3. Insights into the inhibitory mechanisms of NADH on the αγ heterodimer of human NAD-dependent isocitrate dehydrogenase. Scientific Reports (2018).
4. Enzymatic Characterization of the Isocitrate Dehydrogenase with Dual Coenzyme Specificity from the Marine Bacterium Umbonibacter marinipuiceus. International Journal of Molecular Sciences (2023).
5. Structure and allosteric regulation of human NAD-dependent isocitrate dehydrogenase. Cell Discovery (2020).